Get a full analysis report for any ticker →

SECTOR COVERAGE

Stock Upgrades & Downgrades

32 STORIES · UPDATED NOV 2

An analyst upgrade is a signal, not a verdict. We cover the rating changes as they land and pressure-test each one against valuation and the underlying fundamentals, so you can tell a genuine inflection from a chase.

Top StoryRIVN

UBS Upgrades Rivian Despite Insider Selling Near Recent Highs

UBS upgraded Rivian on Monday, citing R2 demand and margin outlook, driving a 12.1% single-session rally after the stock fell 19% on Q3 earnings. The timing is awkward: every insider open-market sale in the preceding 90 days cleared between $14.50 and $16.29, all above the current $13.24 recovery price.

AVTRAnalysis-4%

Avantor Gets Buy Upgrade; Stock Drops 4% on Earnings

Avantor earned a Zacks Buy upgrade and achieved its fourth consecutive earnings beat in Q3, with net income swinging $915 million to a $203.4 million …

CRWVAnalysis

Goldman Upgrades CoreWeave; Every Insider Sold Higher

Goldman Sachs upgraded CoreWeave to Buy on Monday, citing the AI infrastructure provider's 112.5% revenue growth and $6.91 billion in operating cash f…

ERIEAnalysis

Erie Gets Buy Upgrade as Stock Extends 2026 Decline

A Buy upgrade of Erie Indemnity sparked a brief 3.6% gain that evaporated within days, leaving the stock down on the year despite strong free cash flo…

PCORAnalysis

Procore Insiders Sell as Analysts Call Stock Undervalued

Procore earned a Zacks analyst upgrade and undervalued designation on September 4, the same day a director sold shares, extending a 90-day insider sel…

BAXAnalysis+4.1%

Baxter Stock Surges 4.1% as Citi Issues Downgrade

Citi downgraded Baxter International on June 10, 2026, warning of a tough road ahead, even as shares rose 4.1% the same day. The divergence follows an…

ENPHAnalysis

Enphase CEO Buys $337K in Stock Above Analyst Target

Enphase Energy CEO Badrinarayanan Kothandaraman purchased 5,000 shares on the open market at $67–68, roughly 55% above the analyst consensus target of…

HBMAnalysis

TSX Approves Hudbay 5% Buyback; Barclays Goes Overweight

Hudbay Minerals secured TSX approval to repurchase up to 5% of its outstanding shares while Barclays initiated coverage with an Overweight rating, sup…

YMMAnalysis

Full Truck Alliance Stock Upgraded to Buy After Q1

Full Truck Alliance reported Q1 2026 EPS of $1.27 against a $1.18 consensus, earned a Buy upgrade with a $20 analyst target, and has committed to appr…

SIMOAnalysis

Silicon Motion Wins Auto Safety Cert as 2026 Surge Holds

Silicon Motion earned an automotive safety certification and received a B. Riley price target increase this week, adding catalysts to a stock already …

INTRAnalysis

Citi Cuts Inter & Co to Neutral, Sees Limited Upside

Citigroup downgraded Inter & Co to neutral with a $6.50 price target, arguing the stock's re-rating already reflects its improving return-on-equity tr…

CYTKAnalysis+20%

CYTK Surges 20% on HCM Data; Offering Filed, Execs Sell

Cytokinetics shares jumped roughly 20% on May 5 after an HCM trial outcome pushed the stock to two-year highs, but the company immediately filed two s…

ELFAnalysis

ELF Executives Sell $13M as Stock Slides to 52-Week Low

Six e.l.f. Beauty executives sold more than $10 million in shares on a single day in late April 2026, just 72 hours after receiving equity grants, as …

GMEBrief

GameStop Wants to Buy eBay for $100 Billion. It Has $4.6 Billion.

GameStop is reportedly preparing a bid for eBay this month targeting a combined $100 billion entity, but with only $4.6 billion in cash against eBay's…

PTONAnalysis

Peloton Insiders Sell $2.2M Ahead of Q3 Report

Six Peloton executives sold a combined $2.19 million in stock over the past 90 days with zero insider purchases, ahead of the company's fiscal Q3 2026…

BLDAnalysis

QXO to Buy TopBuild for $17B at $505/Share

QXO has agreed to acquire TopBuild Corp. for approximately $17 billion at $505 per share in stock and cash, a 23% premium to recent trading levels. Th…

DTAnalysis

Dynatrace: Analyst Targets Drop, Insider Steps In

Dynatrace shares trade at a 27% discount to consensus after TD Cowen and Truist both lowered price targets, even as EVP Stephen McMahon made a notable…

EQHAnalysis

EQH: $58 Strong Buy — Buyback Before Merger?

Management is reportedly considering a share repurchase before the Corebridge merger closes, an unusual step that would shrink EQH's share count at a …

JBLUAnalysis

JetBlue Is Losing $1.2 Billion a Year But Trading Above Every Analyst Target — The Takeover Explains Why

JetBlue is granting United Airlines physical gate access at JFK's Terminal 6 and enabling cross-network booking with cash or points, mirroring the ope…

WINGBrief

Morgan Stanley Cuts Wingstop Price Target 23% but Still Says Buy the Dip

Morgan Stanley cut its Wingstop price target to $265 from $345 while maintaining an Overweight rating, expecting a Q1 earnings miss but calling the ri…

VFSAnalysis-42%

VFS: -42% Gross Margin, +45% Price Target?

VinFast's earnings misses are accelerating quarter over quarter, from -7.3% to -30.2% to -41.7%, even as revenue grows 139%. A negative 42.5% gross ma…

BOOTBrief

Boot Barn Holdings Gets Jefferies Upgrade to Buy With 31% Upside to $195

Jefferies upgraded Boot Barn Holdings to Buy with a $195 price target, seeing 31% upside after the stock's valuation reset brought shares to 17.6x for…

SLNOAnalysis

Soleno Therapeutics Is Trading 63% Below Its Lowest Price Target While a $2.5 Billion Buyer Circles

Soleno Therapeutics trades at $39.49, a 63% discount to Oppenheimer's recently slashed $80 target, while Neurocrine reportedly circles with a $2.5 bil…

KALUBrief

Kaiser Aluminum Stock Outruns New $127 Price Target as Aluminum Sector Surges

An analyst raised Kaiser Aluminum's price target to $127, but the stock already trades near $132 as a tariff-driven "aluminum is the new oil" narrativ…

MLYSAnalysis

Mineralys Therapeutics Just Lost Its Most Important Drug Trial: and Analysts Still Say Buy

The Explore-OSA trial failure eliminates lorundrostat's most differentiated indication expansion, leaving Mineralys to compete head-to-head against As…

CNTABrief

Eli Lilly to Buy Centessa Pharmaceuticals for Up to $7.8bn in Neuro Push

Eli Lilly announced a deal to acquire Centessa Pharmaceuticals for up to $7.8bn, paying $6.3bn upfront to secure the biotech's orexin receptor pipelin…

AGROBrief

UBS Doubles Adecoagro Price Target to $16.20, Upgrades to Buy

UBS more than doubled its Adecoagro S.A. (AGRO) price target to $16.20 from $8.00 and upgraded the stock to Buy from Neutral, a major Wall Street re-r…

GRDNBrief+9.1%

Jefferies Initiates GRDN at Buy With $44 Target, Stock Surges 9.1%

Jefferies initiated Guardian Pharmacy Services (GRDN) at Buy with a $44 price target Monday, sparking a 9.1% single-day rally and establishing institu…

CLMTBrief

Calumet (CLMT) Gets 82% Price Target Hike to $60 by H.C. Wainwright

H.C. Wainwright raised its price target on Calumet, Inc. (CLMT) 82% to $60 from $33, citing a $115mn YoY swing in operating cash flow and an imminent …

BRZEAnalysis

Braze Price Target Slashed 35% by UBS While Street Stays Bullish at $35

UBS dramatically cut Braze's price target by 35% from $43 to $28 while maintaining a Buy rating, creating a massive disconnect with the $35.10 Street …

ARXAnalysis

Wells Fargo Upgrades Accelerant but Slashes Price Target 12% to $15

Wells Fargo upgraded Accelerant Holdings to Overweight but simultaneously cut its price target 12% from $17 to $15. This rare upgrade-with-lower-targe…

INTCAnalysis

Intel Analyst Split Creates 75% Price Range Gap After 68% Stock Decline

Wall Street analysts are simultaneously issuing 32-43% downside targets for Intel while value investors call it an incredible opportunity after a 68% …

Keep going

Your move

Run this same teardown on a stock you actually own.

Drop in any ticker and get an institutional-grade report in about 60 seconds — the full DCF, an earnings-quality score, and the red flags buried deep in the filing. No signup, no card.

Run a free report →
  • DCF valuation with bull & bear cases
  • Earnings-quality score from 0–100
  • Red-flag scan across the 10-K
  • Peer multiples & a fair-value range